Blockade of the CXCR4 signaling is hypothesized to not only decrease tumor angiogenesis but also decrease the number of cancer stem cells and increase mobilization and recruitment of effector T cells into the TME (166) (Table 7). The gene discussed is CXCR4; the disease is neoplasm.